Canal-U

Mon compte

Résultats de recherche

Nombre de programmes trouvés : 6593
Label UNT Documentaires

le (12m49s)

La Maison positive

La Maison positive retrace une aventure pédagogique menée au Lycée professionnel du Sidobre à Castres, (Tarn, France) en 2010-2011 : la construction d'une maison à énergie positive par les lycéens eux-mêmes. Ce projet éducatif et écologique, conduit par Jean-Michel Decuq, professeur de génie climatique au Lycée du Sidobre, se veut être une illustration des multiples actions pédagogiques menées dans les établissements scolaires conçues pour l'éducation au développement durable.Au delà de la sensibilisation aux enjeux écologiques et aux techniques de l'habitat durable, le film montre comment ce projet d'éco-construction a réussi à fédérer l'ensemble de la communauté scolaire du lycée, dépassant ...
Voir la vidéo
Conférences

le (50m43s)

Regulating EBM standards: Guidelines for guideline development

Regulating EBM standards: Guidelines for guideline developmentMy doctoral dissertation is entitled In search of standards that avoid standardization: the production and regulation of evidence based guidelines. Based on document analysis, interviews and (participant) observation of EBM guideline development ‘in action’, it provides ethnographic insight into the question how norms and standards of care are produced in the everyday activities of EBM. EBM guidelines have invoked promises of gold standards based on universal evidence that will rationalize practices, as well as criticism of standards transforming the ‘art’ of medicine into a dehumanized uniformity that deskills professionals and ignores the uniqueness of ...
Voir la vidéo
Conférences

le (22m24s)

Preuves incertaines : échelles, corps et environnements dans les sciences de l’obésité

Uncertain evidence: scales, bodies and environments in obesity science This paper examines the uncertainties raised by flows operating between the production of evidence and the making of policy in the field of nutrition. Public health initiatives have been launched worldwide in the wake of the 21st century to tackle non-communicable, chronic disease associated with high body mass indexes. Although the causes and means of calculating the rising rates of obesity are contested and uncertain, obesity is often characterised as a disease or epidemic. Given this context of uncertainty concerning how to qualify and circumscribe the “problem,” let alone define its aetiology, ...
Voir la vidéo
Conférences

le (29m9s)

Experimental Communities: Mediating locality in clinical trial sites in South Africa

Experimental Communities: Mediating locality in clinical trial sites in South AfricaMore than twenty years into the HIV epidemic in South Africa, the impacts of HIV/AIDS and other diseases, and the research and interventions they have mobilised, have reconfigured many elements of social life for South Africans. At this moment, however, much seems to be shifting as approaches to both HIV prevention and care have become increasingly biomedical, and as large populations are surveyed, tested, and enrolled in complex and costly medical regimes. Some researchers have referred to this phenomenon, in particular as “the greatest public health experiment in Africa,” a ...
Voir la vidéo
Conférences

le (23m46s)

Randomised controlled trials, health agencies and consumer organisations

Randomised controlled trials, health agencies and consumer organisations: the case of Intrinsa and FlibanserinRandomized controlled trials (RCT) are now considered the ‘gold standard’ of clinical evidence (Timmermans, Berg, 2003), providing scientific and clinical proof, opening the door to the approval of new treatments by local health agencies, and legitimizing the use of a treatment. The studies of male circumcision for HIV prevention in several countries in Southern Africa constitute one of the clearest examples of such a use of RCTs by international public health agencies (WHO, UNAIDS), who here based the development of a public health recommendation on the publication ...
Voir la vidéo
Label UNT Conférences

le (1h15m0s)

Y-a-t-il une barrière entre l'homme et l'animal ?

Alain ProchiantzLa question n'est pas "Être OU ne pas être un animal" mais "être ET ne pas être un animal"Qu'appelle t-on la "culture chimpanzée" ?Ce sont toujours les humains qui écrivent sur les chimpanzés et pas l'inverse !L'approche des biologistes : les différences entre les gènes humains et animaux (chimpanzés).La conscience, l'angoisse, la solitude.Dominique LestelComment caractériser l'homme par rapport à l'animal ?Les écrivains (exemple de Romain Gary), les philosophes, les scientifiques ont essayé de déterminer le "propre de l'homme".Le langage et ses caractéristiques, La bipédie, les critères intellectuels (le travail, l'outil...)Les humains sont ils aptes à se comparer à l'animal ...
Voir la vidéo
Conférences

le (24m41s)

Gouverner (par) les bactéries: la surveillance épidémiologique comme « dispositif-frontière »

Governing (through) bacteria: epidemiological surveillance as "boundary-device". The case of antimicrobial resistance in veterinary medicineThe problem of antimicrobial resistance emerged in the late 1990's. Most of bacteria being zoonotic, it concerns human medicine as well as veterinary medicine. In November 2011, the French ministry of Agriculture implemented a plan for the fight against antimicrobial resistance in veterinary medicine in order to better control the use of antibiotics in livestock production. One of the main measures of this policy is to reinforce the epidemiological surveillance system of bacteria of animal origin : the "Resapath". This presentation aims at studying how this epidemiological ...
Voir la vidéo
Conférences

le (25m25s)

The rise of cost-effectiveness evidence in global health

The rise of cost-effectiveness evidence in global health: contingencies of ‘context’ and the politics of contingency The development and implementation of health policies in developing countries have become increasingly driven by the practices of research communities, inter- and non-governmental organisations, and donor agencies operating at the global level.  As part of this shifting landscape, commentators have noted the permeation of neo-liberal market-principles into global health with the rise of “philanthrocapitalism” and public-private partnerships, starting mostly in the 1990s. Thus, critics argue that the concurrent rise in demand for experimental evidence of cost-effectiveness reflects not simply the superior epistemic truth-value now attributed ...
Voir la vidéo
Conférences

le (24m53s)

Flipping the Hierarchy of Evidence ?

Flipping the Hierarchy of Evidence ? : Rituals of Inversion and Subversion in the Inclusion of Qualitative Research in WHO GuidelinesEvidence-based medicine (EBM)—and its hallmark method, meta-analysis—have enjoyed rapidly increasing visibility and legitimacy since the early 1990s.  The many assumptions of EBM—that valid, universal knowledge can be produced, that knowledge synthesis can be rigorous and transparent, and that these syntheses will slot neatly into policy and practice—have come to appear self-evident.  The rhetoric of “evidence-based” practice frames evidence synthesis as both common sense, with respect to orthodox scientific method, and, paradoxically, a radical break with a past practice steeped in ...
Voir la vidéo
Conférences

le (1h30m9s)

Usages politiques et sociaux du registre biomédical

Bauer SusanneModeling population health. Reflections on the performativity of epidemiological techniques in the age of genomics Like accounting in the world of business, practices of quantification at the population level are ubiquitous in the health sciences. Risk reasoning has become the common sense mode of knowledge production in the health sciences. Risk assessment techniques of modern epidemiology also co-shape the ways genomic data are translated into population health. The products of these computational practices – risk figures – fold into the very configurations of health matters, co-shaping the body politic in biomedical science, clinical practice and everyday life. In preventive medicine, ...
Voir la vidéo

 
FMSH
 
Facebook Twitter Google+
Mon Compte